Skip to content
lsd.com

Indication

Parkinson's Disease

3 registered trials testing Ketamine for this indication, 1 recruiting now.

3
Registered trials
1
Recruiting
0
In Phase 3

Stay told

When a new trial opens

Research alerts

Get a notification when a trial for Parkinson's Disease trials starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

Trials

All 3 trials for Parkinson's Disease

TrialStatusPhaseSubstanceSites
Imaging Depression in Parkinson's DiseaseNCT06402955 · Yale UniversityRecruitingPhase 2ketamine1
Ketamine for the Treatment of Depression in Parkinson's DiseaseNCT04944017 · Yale UniversityCompletedPhase 2ketamine1
Long Term Follow Up KET-PDNCT06164756 · Yale UniversityEnrolling by invitationN/Aketamine1

Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.